Alteration of the insulin-like growth factor axis during in vitro differentiation of the human osteosarcoma cell line HOS 58

Journal of Cellular Biochemistry

Volumn 102, Issue 1, 2007, Pages 28-40

  Viereck, Volker ^a   Siggelkow, Heide ^a   Pannem, Rajeswararao ^a   Braulke, Thomas ^b   Scharf, Jens Gerd ^a,c   Kübler, Bernd ^b  

^a UNIVERSITY OF GÖTTINGEN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY MEDICAL CENTER GÖTTINGEN   (Germany)

Author keywords

Differentiation; IGF; IGF binding proteins; IGF receptor; Osteoblast like cells

Indexed keywords

SOMATOMEDIN; SOMATOMEDIN B; SOMATOMEDIN B RECEPTOR; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 2; SOMATOMEDIN BINDING PROTEIN 3; SOMATOMEDIN BINDING PROTEIN 4; SOMATOMEDIN BINDING PROTEIN 5; SOMATOMEDIN C; SOMATOMEDIN C RECEPTOR;

ARTICLE; CANCER CELL CULTURE; CELL DENSITY; CELL DIFFERENTIATION; CELL MATURATION; CELL PROLIFERATION; CONTROLLED STUDY; HUMAN; HUMAN CELL; OSTEOSARCOMA; PRIORITY JOURNAL;

BONE NEOPLASMS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CELL PROLIFERATION; HUMANS; INSULIN-LIKE GROWTH FACTOR BINDING PROTEINS; INSULIN-LIKE GROWTH FACTOR I; INSULIN-LIKE GROWTH FACTOR II; OSTEOBLASTS; OSTEOSARCOMA; RECEPTOR, IGF TYPE 1; RECEPTOR, IGF TYPE 2; RECEPTORS, SOMATOMEDIN; RNA, MESSENGER; SOMATOMEDINS;

EID: 34548500093     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.21274     Document Type: Article

References (56)

1. Aerssens J, Boonen S, Lowet G, Dequeker J. 1998. Interspecies differences in bone composition, density, and quality: Potential implications for in vivo bone research. Endocrinology 139:663-670.
2. Bautista CM, Baylink DJ, Mohan S. 1991. Isolation of a novel insulin-like growth factor (IGF) binding protein from human bone: A potential candidate for fixing IGF-II in human bone. Biochem Biophys Res Commun 176:756-763.
3. Bell GI, Gerhard DS, Fong NM, Sanchez-Pescador R, Rall LB. 1985. Isolation of the human insulin-like growth factor genes: Insulin-like growth factor II and insulin genes are contiguous. Proc Natl Acad Sci USA 82:6450-6454.
4. Birnbaum RS, Bowsher RR, Wiren KM. 1995. Changes in IGF-I and -II expression and secretion during the proliferation and differentiation of normal rat osteoblasts. J Endocrinol 144:251-259.
5. Braulke T. 1999. Type-2 IGF receptor: A multi-ligand binding protein. Horm Metab Res 31:242-246.
6. Canalis E, Centrella M, Burch W, McCarthy TL. 1989. Insulin-like growth factor I mediates selective anabolic effects of parathyroid hormone in bone cultures. J Clin Invest 83:60-65.
7. Clemmons DR. 1997. Insulin-like growth factor binding proteins and their role in controlling IGF actions. Cytokine Growth Factor Rev 8:45-62.
8. Conover CA. 1995. Insulin-like growth factor binding protein proteolysis in bone cell models. Prog Growth Factor Res 6:301-309.
9. Conover CA. 2000. In vitro studies of insulin-like growth factor I and bone. Growth Horm IGF Res 10 Suppl B: S107-S110.
10. Conover CA, Khosla S. 2003. Role of extracellular matrix in insulin-like growth factor (IGF) binding protein-2 regulation of IGF-II action in normal human osteoblasts. Growth Horm IGF Res 13:328-335.
11. Conover CA, Johnstone EW, Turner RT, Evans GL, John Ballard FJ, Doran PM, Khosla S. 2002. Subcutaneous administration of insulin-like growth factor (IGF)-II/IGF binding protein-2 complex stimulates bone formation and prevents loss of bone mineral density in a rat model of disuse osteoporosis. Growth Horm IGF Res 12:178-183.
12. Durham SK, Riggs BL, Harris SA, Conover CA. 1995. Alterations in insulin-like growth factor (IGF)-dependent IGF-binding protein-4 proteolysis in transformed osteoblastic cells. Endocrinology 136:1374-1380.
13. Eckstein F, Pavicic T, Nedbal S, Schmidt C, Wehr U, Rambeck W, Wolf E, Hoeflich A. 2002. Insulin-like growth factor-binding protein-2 (IGFBP-2) overexpression negatively regulates bone size and mass, but not density, in the absence and presence of growth hormone/IGF-I excess in transgenic mice. Anat Embryol (Berl) 206:139-148.
14. Ernst M, Rodan GA. 1990. Increased activity of insulin-like growth factor (IGF) in osteoblastic cells in the presence of growth hormone (GH): Positive correlation with the presence of the GH-induced IGF-binding protein BP-3. Endocrinology 127:807-814.
15. Feyen JH, Evans DB, Binkert C, Heinrich GF, Geisse S, Kocher HP. 1991. Recombinant human [Cys281]insulin-like growth factor-binding protein 2 inhibits both basal and insulin-like growth factor I-stimulated proliferation and collagen synthesis in fetal rat calvariae. J Biol Chem 266:19469-19474.
16. Firth SM, Baxter RC. 2002. Cellular actions of the insulin-like growth factor binding proteins. Endocrinol Rev 23:824-854.
17. Govoni KE, Baylink DJ, Mohan S. 2005. The multi-functional role of insulin-like growth factor binding proteins in bone. Pediatr Nephrol 20:261-268.
18. Hossenlopp P, Seurin D, Segovia-Quinson B, Hardouin S, Binoux M. 1986. Analysis of serum insulin-like growth factor binding proteins using western blotting: Use of the method for titration of the binding proteins and competitive binding studies. Anal Biochem 154:138-143.
19. Jones JI, Clemmons DR. 1995. Insulin-like growth factors and their binding proteins: Biological actions. Endocrinol Rev 16:3-34.
20. Jones JI, Gockerman A, Busby WH Jr, Camacho-Hubner C, Clemmons DR. 1993. Extracellular matrix contains insulin-like growth factor binding protein-5: Potentiation of the effects of IGF-I. J Cell Biol 121:679-687.
21. Jonsson KB, Ljunghall S, Karlstrom O, Johansson AG, Mallmin H, Ljunggren O. 1993. Insulin-like growth factor I enhances the formation of type I collagen in hydrocortisone-treated human osteoblasts. Biosci Rep 13:297-302.
22. Kanzaki S, Hilliker S, Baylink DJ, Mohan S. 1994. Evidence that human bone cells in culture produce insulin-like growth factor-binding protein-4 and -5 proteases. Endocrinology 134:383-392.
23. Kassem M, Okazaki R, De Leon D, Harris SA, Robinson JA, Spelsberg TC, Conover CA, Riggs BL. 1996. Potential mechanism of estrogen-mediated decrease in bone formation: Estrogen increases production of inhibitory insulin-like growth factor-binding protein-4. Proc Assoc Am Physicians 108:155-164.
24. Khosla S, Hassoun AA, Baker BK, Liu F, Zein NN, Whyte MP, Reasner CA, Nippoldt TB, Tiegs RD, Hintz RL, Conover CA. 1998. Insulin-like growth factor system abnormalities in hepatitis C-associated osteosclerosis:-Potential insights into increasing bone mass in adults. J Clin Invest 101:2165-2173.
25. Kiefer MC, Masiarz FR, Bauer DM, Zapf J. 1991. Identification and molecular cloning of two new 30-kDa insulin-like growth factor binding proteins isolated from adult human serum. J Biol Chem 266:9043-9049.
26. Kiefer MC, Schmid C, Waldvogel M, Schlapfer I, Futo E, Masiarz FR, Green K, Barr PJ, Zapf J. 1992. Characterization of recombinant human insulin-like growth factor binding proteins 4,5,and 6 produced in yeast. J Biol Chem 267:12692-12699.
27. Kubler B, Cowell S, Zapf J, Braulke T. 1998. Proteolysis of insulin-like growth factor binding proteins by a novel 50-kilodalton metalloproteinase in human pregnancy serum. Endocrinology 139:1556-1563.
28. Lalou C, Silve C, Rosato R, Segovia B, Binoux M. 1994. Interactions between insulin-like growth factor-I (IGF-I) and the system of plasminogen activators and their inhibitors in the control of IGF-binding protein-3 production and proteolysis in human osteosarcoma cells. Endocrinology 135:2318-2326.
29. LaTour D, Mohan S, Linkhart TA, Baylink DJ, Strong DD. 1990. Inhibitory insulin-like growth factor-binding protein: Cloning, complete sequence, and physiological regulation. Mol Endocrinol 4:1806-1814.
30. LeRoith D, Werner H, Beitner-Johnson D, Roberts CT Jr. 1995. Molecular and cellular aspects of the insulin-like growth factor I receptor. Endocrinol Rev 16:143-163.
31. Liu JP, Baker J, Perkins AS, Robertson EJ, Efstratiadis A. 1993. Mice carrying null mutations of the genes encoding insulin-like growth factor I (Igf-1) and type 1 IGF receptor (Igf1r). Cell 75:59-72.
32. Maile LA, Holly JM. 1999. Insulin-like growth factor binding protein (IGFBP) proteolysis: Occurrence, identification, role and regulation. Growth Horm IGF Res 9:85-95.
33. Mohan S, Baylink DJ. 1996. Insulin-like growth factor system components and the coupling of bone formation to resorption. Horm Res 45 Suppl 1:59-62.
34. Mohan S, Baylink DJ. 2002. IGF-binding proteins are multifunctional and act via IGF-dependent and -independent mechanisms. J Endocrinol 175:19-31.
35. Mohan S, Bautista CM, Wergedal J, Baylink DJ. 1989. Isolation of an inhibitory insulin-like growth factor (IGF) binding protein from bone cell-conditioned medium: A potential local regulator of IGF action. Proc Natl Acad Sci USA 86:8338-8342.
36. Okazaki R, Conover CA, Harris SA, Spelsberg TC, Riggs BL. 1995. Normal human osteoblast-like cells consistently express genes for insulin-like growth factors I and II but transformed human osteoblast cell lines do not. J Bone Miner Res 10:788-795.
37. Owen TA, Aronow M, Shalhoub V, Barone LM, Wilming L, Tassinari MS, Kennedy MB, Pockwinse S, Lian JB, Stein GS. 1990. Progressive development of the rat osteoblast phenotype in vitro: Reciprocal relationships in expression of genes associated with osteoblast proliferation and differentiation during formation of the bone extracellular matrix. J Cell Physiol 143:420-430.
38. Raile K, Hoflich A, Kessler U, Yang Y, Pfuender M, Blum WF, Kolb H, Schwarz HP, Kiess W. 1994. Human osteosarcoma (U-2 OS) cells express both insulin-like growth factor-I (IGF-I) receptors and insulin-like growth factor-II/mannose-6-phosphate (IGF-II/M6P) receptors and synthesize IGF-II: Autocrine growth stimulation by IGF-II via the IGF-I receptor. J Cell Physiol 159:531-541.
39. Rickard DJ, Kassem M, Hefferan TE, Sarkar G, Spelsberg TC, Riggs BL. 1996. Isolation and characterization of osteoblast precursor cells from human bone marrow. J Bone Miner Res 11:312-324.
40. Rosen CJ, Donahue LR. 1998. Insulin-like growth factors and bone: The osteoporosis connection revisited. Proc Soc Exp Biol Med 219:1-7.
41. Scharf J, Ramadori G, Braulke T, Hartmann H. 1996. Synthesis of insulinlike growth factor binding proteins and of the acid-labile subunit in primary cultures of rat hepatocytes, of Kupffer cells, and in cocultures: Regulation by insulin, insulinlike growth factor, and growth hormone. Hepatology 23:818-827.
42. Scharf JG, Knittel T, Dombrowski F, Muller L, Saile B, Braulke T, Hartmann H, Ramadori G. 1998a. Characterization of the IGF axis components in isolated rat hepatic stellate cells. Hepatology 27:1275-1284.
43. Scharf JG, Schmidt-Sandte W, Pahernik SA, Ramadori G, Braulke T, Hartmann H. 1998b. Characterization of the insulin-like growth factor axis in a human hepatoma cell line (PLC). Carcinogenesis 19:2121-2128.
44. Seck T, Scheppach B, Scharla S, Diel I, Blum WF, Bismar H, Schmid G, Krempien B, Ziegler R, Pfeilschifter J. 1998. Concentration of insulin-like growth factor (IGF)-I and -II in iliac crest bone matrix from pre-and postmenopausal women: Relationship to age, menopause, bone turnover, bone volume, and circulating IGFs. J Clin Endocrinol Metab 83:2331-2337.
45. Shalamanova L, Kubler B, Scharf JG, Braulke T. 2001. MDCK cells secrete neutral proteases cleaving insulin-like growth factor-binding protein-2 to -6. Am J Physiol Endocrinol Metab 281:E1221-E1229.
46. Shimasaki S, Ling N. 1991. Identification and molecular characterization of insulin-like growth factor binding proteins (IGFBP-1, -2, -3, -4, -5 and -6). Prog Growth Factor Res 3:243-266.
47. Siggelkow H, Niedhart C, Kurre W, Ihbe A, Schulz A, Atkinson MJ, Hufner M. 1998. In vitro differentiation potential of a new human osteosarcoma cell line (HOS 58). Differentiation 63:81-91.
48. Siggelkow H, Rebenstorff K, Kurre W, Niedhart C, Engel I, Schulz H, Atkinson MJ, Hufner M. 1999. Development of the osteoblast phenotype in primary human osteoblasts in culture: Comparison with rat calvarial cells in osteoblast differentiation. J Cell Biochem 75:22-35.
49. Siggelkow H, Schenck M, Rohde M, Viereck V, Tauber S, Atkinson MJ, Hufner M. 2002. Prolonged culture of HOS 58 human osteosarcoma cells with 1,25-(OH)2-D3, TGF-beta, and dexamethasone reveals physiological regulation of alkaline phosphatase, dissociated osteocalcin gene expression, and protein synthesis and lack of mineralization. J Cell Biochem 85:279-294.
50. Siggelkow H, Schmidt E, Hennies B, Hufner M. 2004. Evidence of downregulation of matrix extracellular phosphoglycoprotein during terminal differentiation in human osteoblasts. Bone 35:570-576.
51. Silha JV, Mishra S, Rosen CJ, Beamer WG, Turner RT, Powell DR, Murphy LJ. 2003. Perturbations in bone formation and resorption in insulin-like growth factor binding protein-3 transgenic mice. J Bone Miner Res 18:1834-1841.
52. Ullrich A, Gray A, Tam AW, Yang-Feng T, Tsubokawa M, Collins C, Henzel W, Le Bon T, Kathuria S, Chen E, et al. 1986. Insulin-like growth factor I receptor primary structure: Comparison with insulin receptor suggests structural determinants that define functional specificity. Embo J 5:2503-2512.
53. Viereck V, Grundker C, Blaschke S, Niederkleine B, Siggelkow H, Frosch KH, Raddatz D, Emons G, Hofbauer LC. 2003. Raloxifene concurrently stimulates osteoprotegerin and inhibits interleukin-6 production by human trabecular osteoblasts. J Clin Endocrinol Metab 88:4206-4213.
54. Wergedal JE, Mohan S, Lundy M, Baylink DJ. 1990. Skeletal growth factor and other growth factors known to be present in bone matrix stimulate proliferation and protein synthesis in human bone cells. J Bone Miner Res 5:179-186.
55. Zhang M, Xuan S, Bouxsein ML, von Stechow D, Akeno N, Faugere MC, Malluche H, Zhao G, Rosen CJ, Efstratiadis A, Clemens TL. 2002. Osteoblast-specific knockout of the insulin-like growth factor (IGF) receptor gene reveals an essential role of IGF signaling in bone matrix mineralization. J Biol Chem 277:44005-44012.
56. Zhang M, Faugere MC, Malluche H, Rosen CJ, Chernausek SD, Clemens TL. 2003. Paracrine overexpression of IGFBP-4 in osteoblasts of transgenic mice decreases bone turnover and causes global growth retardation. J Bone Miner Res 18:836-843.